LONDON May 12 The GAVI global vaccine alliance
said on Friday some 300,000 emergency doses of an Ebola vaccine
developed by Merck could be available in case of a
large-scale outbreak, after the World Health Organization
confirmed a fatal case in Congo.
The vaccine, known as rVSV-ZEBOV, was shown to be highly
protective against Ebola in clinical trials published last
A spokesman for the World Health Organization told Reuters
on Friday that a person in the Democratic Republic of Congo had
died after becoming infected with Ebola - a contagious virus
that causes haemorrhagic fever.
(Reporting by Kate Kelland; Editing by Hugh Lawson)